Ligand Pharmaceuticals LGND Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's common stock, shares, outstanding?
- Ligand Pharmaceuticals (LGND) reported common stock, shares, outstanding of $20.03M in Q1 2026.
- How has Ligand Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
- Ligand Pharmaceuticals's common stock, shares, outstanding increased by 3.9% year-over-year, from $19.28M to $20.03M.
- What is the long-term trend for Ligand Pharmaceuticals's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's common stock, shares, outstanding has grown at a 4.2% compound annual growth rate (CAGR), from $16.08M to $19.77M.